ERAS•benzinga•
Erasca Reveals Reduction In Workforce By ~18%, In Connection With Strategic Reprioritization, Primarily Affecting Employees Working In Drug Discovery Functions Or On Deprioritized Programs - Filing
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2024 by benzinga